We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · March 01, 2021

Junction Plakoglobin Regulates and Destabilizes HIF2α to Inhibit Tumorigenesis of RCC

Cancer communications (London, England)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer communications (London, England)
Junction Plakoglobin Regulates and Destabilizes HIF2α to Inhibit Tumorigenesis of Renal Cell Carcinoma
Cancer Commun (Lond) 2021 Feb 16;[EPub Ahead of Print], K Chen, J Zeng, Y Sun, W Ouyang, G Yu, H Zhou, Y Zhang, W Yao, W Xiao, J Hu, J Xing, K Xiao, L Wu, Z Chen, Z Ye, H Xu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading